Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

(SBUX, CTIC) CRWEFinance.com Watch List for Friday Nov. 5, 2010

|Includes: CTI BioPharma Corp. (CTIC), SBUX

crwefinancelogo2

chartstockalert

__

sbux   SBUX, Starbucks Corp.

SBUX has been committed to ethically sourcing and roasting the highest quality arabica coffee in the world. Today, with stores around the globe, SBUX is the premier roaster and retailer of specialty coffee in the world.

** Starbucks Reports Record Fourth Quarter and Fiscal 2010 Results **

- Q4 EPS Up 85% to $0.37; Non-GAAP EPS Up 54% to $0.37

- Q4 Global Comparable Store Sales Increase 8%; Global Traffic Increases 5%

- Q4 Operating Margin Up Sharply, to 17.3% in U.S. and 13.8% Internationally

More about SBUX at www.starbucks.com.

*********************

ctic   CTIC, Cell Therapeutics, Inc.

CTIC is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable.

** CTIC has been awarded recently $977,917 in grants under the Therapeutic Discovery Tax Credit program that was enacted under the U.S. government's Patient Protection and Affordable Care Act.

The program targets projects that show potential to produce new therapies, address unmet medical needs, reduce the long-term growth of health care costs and advance the goal of curing cancer.

CTIC was awarded the grants for CTIC's programs pixantrone, OPAXIO, brostallicin and bisplatinates which are all focused in the area of oncology.  

Furthermore, CTIC will ask the European Medicines Agency (NYSEMKT:EMA) for approval of the pixantrone dimaleate treatment for non-Hodgkin’s lymphoma.

More about CTIC at www.celltherapeutics.com

********************************************************************

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.